Baillie Gifford - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 108 filers reported holding INTERSECT ENT INC in Q2 2021. The put-call ratio across all filers is 2.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$12,0000.0%4400.0%0.00%
Q4 2021$12,0000.0%4400.0%0.00%
Q3 2021$12,000
+100.0%
440
+21.9%
0.00%
Q2 2021$6,000
-25.0%
3610.0%0.00%
Q1 2021$8,0000.0%361
+6.2%
0.00%
Q4 2020$8,0003400.00%
Other shareholders
INTERSECT ENT INC shareholders Q2 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 700,000$11,963,0002.51%
First Light Asset Management, LLC 2,210,970$37,785,0002.27%
Altium Capital Management LP 182,456$3,118,0000.72%
Rock Springs Capital Management LP 1,220,000$20,850,0000.41%
Novo Holdings A/S 508,922$8,697,0000.39%
PURA VIDA INVESTMENTS, LLC 531,229$9,079,0000.28%
Eversept Partners, LP 175,389$2,997,3980.20%
Polar Asset Management Partners Inc. 801,628$13,700,0000.14%
HighMark Wealth Management LLC 9,575$164,0000.12%
Bellevue Group AG 617,968$10,561,0000.10%
View complete list of INTERSECT ENT INC shareholders